首页> 美国卫生研究院文献>Research and Practice in Thrombosis and Haemostasis >The effect of unfractionated heparin enoxaparin and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false‐positive results?

【2h】

The effect of unfractionated heparin enoxaparin and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false‐positive results?

机译：普通肝素依诺肝素和丹那普利对狼疮抗凝试验的影响：活性炭能否消除假阳性结果？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Heparins and heparinoids interfere with functional clotting assays used for lupus anticoagulant (LAC) detection. However, current guidelines for LAC testing do not provide clear guidance on this matter.

机译：肝素和类肝素干扰用于狼疮抗凝（LAC）检测的功能性凝血分析。但是，当前的LAC测试指南并未对此问题提供明确的指导。

著录项

期刊名称 Research and Practice in Thrombosis and Haemostasis
作者
Pieter M.M. De Kesel; Katrien M.J. Devreese;
展开▼
作者单位

展开▼
年(卷),期 2020(4),1
年度 2020
页码 -1
总页数 8
原文格式 PDF
正文语种
中图分类心血管疾病 ;
关键词
carbon; danaparoid; enoxaparin; heparin; lupus coagulation inhibitor;

机译：碳;丹那普罗;依诺肝素;肝素;狼疮凝血抑制剂;

相似文献

外文文献
中文文献
专利

1. The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false‐positive results? [J] . Pieter M.M. De Kesel, Katrien M.J. Devreese Research and practice in thrombosis and haemostasis. . 2020 ,第1期

机译：未分割的肝素，脑己素和DanaParoid对狼疮抗凝试验的影响：可以激活碳消除假阳性结果吗？
2. Frequent false-positive results of lupus anticoagulant tests in plasmas of patients receiving the new oral anticoagulants and enoxaparin. [J] . M E Martinuzzo, L H Barrera, M A D adamo, International journal of laboratory hematology . 2014 ,第2期

机译：接受新型口服抗凝剂和依诺肝素治疗的患者血浆中狼疮抗凝试验的假阳性结果频繁。
3. Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives [J] . Favaloro Emmanuel J., Mohammed Soma, Curnow Jennifer, Pathology . 2019 ,第3期

机译：患有直接口服抗凝血剂（DOACS）的患者狼疮抗凝血剂（LA）的实验室检测：误报的潜力和假阴性
4. Physiologically-Based Pharmacokinetic and Pharmacodynamic Modeling of Unfractionated Heparin to Predict Activated Clotting Time [C] . Filippo Regorda, Emiliano Vigoni, Giuseppe Pesenti European Symposium on Computer Aided Chemical engineering . 2020

机译：未分割肝素的基于生理学药代动力学和药效学建模预测激活凝血时间
5. Antithrombin III residue tyrosine-131 serves as a molecular switch during heparin-mediated conformational activation of its anticoagulant activity. [D] . dela Cruz, Richard Glenn Cua. 2006

机译：抗凝血酶III残基酪氨酸131在肝素介导的抗凝活性构象活化过程中充当分子开关。
6. Adverse Outcomes of Anticoagulant Use among Hospitalized Patients with Chronic Kidney Disease: A Comparison of the Rates of Major Bleeding Events between Unfractionated Heparin and Enoxaparin [O] . Fatemeh Saheb Sharif-Askari, Syed Azhar Syed Sulaiman, Narjes Saheb Sharif-Askari, -1

机译：住院的慢性肾脏病患者抗凝药物使用的不良结果：普通肝素和依诺肝素之间主要出血事件发生率的比较
7. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) [O] . Stellbrink, Gerd Christoph, Nixdorff, Uwe, Schmidt-Lucke, Jan-André, 2004

机译：依诺肝素与普通肝素和口服抗凝药相比预防非瓣膜性心房颤动复律中血栓栓塞并发症的安全性和有效性：使用依诺肝素（ACE）进行复律的抗凝作用

The effect of unfractionated heparin enoxaparin and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false‐positive results?

摘要

著录项

相似文献

相关主题

期刊订阅